Pakistan develops homemade anti-Covid vaccine 'PakVac'

[Irfan Baloch]

In a major achievement in its fight against the novel coronavirus, Pakistan on Monday announced that it has developed a homemade vaccine — PakVac — with the help of China's Cansino Bio after rigorous quality control checks.

The step is aimed at significantly reducing Pakistan’s dependence on other countries for Covid-19 vaccine.

The country started its vaccination campaign in February with doses donated by the government of China. The campaign started with frontline healthcare workers and then inoculation of the senior citizens in the second phase.

Pakistan has now started the vaccination of people aged 30 and above. Over five million people have been vaccinated against Covid-19 in the country so far.

Read more: First batch of homemade vaccine to be available by month-end: Umar

"Congratulations to the NIH (National Institute of Health) Pak team and its leadership for successful fill/finish (from concentrate) of the Cansino vaccine with the help of Cansino Bio Inc. China," Special Assistant to Prime Minister on Health Dr Faisal Sultan wrote on his official Twitter handle.


He said that the vaccine has passed rigorous internal quality assurance testing, considering it an important step to help the vaccine supply line.

An official from the Ministry of National Health Services has said that due to the agreement on technology transfer, the NIH would be able to produce three million doses per month.

NHS had announced that the first batch of China’s single-dose CanSino Covid-19 vaccine would be available for administration to the citizens by the end of May.

"The first batch of bulk CanSino vaccine is being processed at the National Institute of Health’s plant, which was set up for this purpose last month, and a specially trained team is working on it," the official said earlier this month.

Also read: Single dose CanSino vaccine to be available for citizens by May end

On Friday, the National Assembly was informed that Pakistan has started local production of anti-Covid vaccine.

Parliamentary Secretary for NHS Nausheen Hamid told the house during question hour that the first batch of CanSino vaccine is currently being manufactured at the NIH.

Pakistan develops homemade anti-Covid vaccine 'PakVac' | The Express Tribune

Pakistan on Monday announced that it has developed a homemade vaccine — PakVac — with the help of China's Cansino Bio after rigorous quality control checks

tribune.com.pk

I hope its not like water car engineering

 

[GumNaam]

shush.
Official WHO website itself today updated Indian vaccination figures to show 200 million vaccinated

200 million brain blood clots!
now

 

[dbc]

Cheap PR stunt by the govt. They are producing Chinese vaccine and changed the name.

its Canadian IP.

CanSino's vaccine, Ad5-nCoV, is built on technology originally developed by Canada's NRC. The company and the research council have been working together since 2013, a relationship that enabled CanSino to license NRC's cell lines.

CanSino, Canada abandon plans for a coronavirus vaccine trial

Canada was set to help CanSino produce its experimental shot as part of a deal to run what would've been the country's first coronavirus vaccine study.

www.biopharmadive.com

 

[OIO]

Pakistan hasn’t developed anything. It simply manufactured the Chinese vaccine and switched the name to PakVac. After the Chinese side wasn’t impressed, they switched back to the original Chinese name for the vaccine.

If Pakistan was a student in school, it will get F for plagiarism.

Pakistan to change name of locally-developed Covid-19 vaccine to CanSino Bio

The National Institute of Health (NIH) is considering reverting to using the name CanSino Bio for the Chinese single-dose coronavirus vaccine being produced at the institute.

120,000 doses of the Covid-19 vaccine have been packed at the NIH, while a launching ceremony is expected to be held by the end of May. For the first batch of 500 doses, the NIH used PakVac, but now it is considering using the name CanSino Bio on the remaining vaccine batches.

"There has been a change of mind and the vaccine would be called CanSino Bio as the Chinese are sensitive about the names of their products," an official of the NIH

Pakistan to change name of locally-developed Covid-19 vaccine to CanSino Bio

* NIH cites name sensitivity as reason for reverting * 'PakVac' was published on the first batch of the vaccine

www.brecorder.com

Brazil's vaccine has also changed its name, but as a new vaccine, it should go through the certification process again.

 

[OIO]

its Canadian IP.

CanSino's vaccine, Ad5-nCoV, is built on technology originally developed by Canada's NRC. The company and the research council have been working together since 2013, a relationship that enabled CanSino to license NRC's cell lines.

CanSino, Canada abandon plans for a coronavirus vaccine trial

Canada was set to help CanSino produce its experimental shot as part of a deal to run what would've been the country's first coronavirus vaccine study.

www.biopharmadive.com

Canada has nothing to do with vaccine research and development. Canada was once a candidate for CanSino Phase III clinical trials but later did not cooperate.

It is very strange that you think Canada has any ability in vaccine research and development.

 

[RealNapster]

I'm 30 and been waiting for weeks to get the vac. No luck .. and sadly even private hospitals in kchi have run out of it.

Register today.

 

[dbc]

Canada has nothing to do with vaccine research and development.

You need to expand your reading list beyond 'The little red book' and 'Xi's thoughts'.

The National Research Council of Canada and CanSino Biologics Inc. announce collaboration to advance vaccine against COVID-19

One of only a handful of vaccine candidates currently in human clinical trials in the world to begin initial evaluation in Canada

www.biospace.com

MONTRÉAL, May 12, 2020 /CNW/ - The National Research Council of Canada (NRC) today announced a collaboration with CanSino Biologics Inc. (CanSinoBIO) to advance bioprocessing and clinical development in Canadaof a candidate vaccine against COVID-19.



The relationship between the NRC and CanSinoBIO was first established in 2013. The NRC's HEK293 cell line was later licensed to CanSinoBIO and used in the development of an approved vaccine against the Ebola virus. The new COVID-19 vaccine is also produced using HEK293 cell lines that were designed and developed at the NRC. By bringing their respective technologies and expertise together to fight COVID-19, CanSino Biologics and the NRC are aiming to pave the way for future clinical trials in Canada, in collaboration with the Canadian Immunization Research Network at the Canadian Center for Vaccinology. The vaccine is subject to approval by Health Canada, for which CanSinoBIO is in the process of filing a Clinical Trial Application (CTA).

This collaboration will allow the NRC to advance a scale-up production process for the vaccine candidate, using its proprietary HEK293 cell line. As a preparatory step, the Government of Canada has already announced $44 million in funding to support upgrades to the NRC's facilities in Montréal to enable compliance with Good Manufacturing Practice (GMP) standards, to ensure readiness for Canadian bioprocessing of potential vaccine candidates as they become available.

 

[OIO]

You need to expand your reading list beyond 'The little red book' and 'Xi's thoughts'.

The National Research Council of Canada and CanSino Biologics Inc. announce collaboration to advance vaccine against COVID-19

One of only a handful of vaccine candidates currently in human clinical trials in the world to begin initial evaluation in Canada

www.biospace.com

MONTRÉAL, May 12, 2020 /CNW/ - The National Research Council of Canada (NRC) today announced a collaboration with CanSino Biologics Inc. (CanSinoBIO) to advance bioprocessing and clinical development in Canadaof a candidate vaccine against COVID-19.



The relationship between the NRC and CanSinoBIO was first established in 2013. The NRC's HEK293 cell line was later licensed to CanSinoBIO and used in the development of an approved vaccine against the Ebola virus. The new COVID-19 vaccine is also produced using HEK293 cell lines that were designed and developed at the NRC. By bringing their respective technologies and expertise together to fight COVID-19, CanSino Biologics and the NRC are aiming to pave the way for future clinical trials in Canada, in collaboration with the Canadian Immunization Research Network at the Canadian Center for Vaccinology. The vaccine is subject to approval by Health Canada, for which CanSinoBIO is in the process of filing a Clinical Trial Application (CTA).

This collaboration will allow the NRC to advance a scale-up production process for the vaccine candidate, using its proprietary HEK293 cell line. As a preparatory step, the Government of Canada has already announced $44 million in funding to support upgrades to the NRC's facilities in Montréal to enable compliance with Good Manufacturing Practice (GMP) standards, to ensure readiness for Canadian bioprocessing of potential vaccine candidates as they become available.

Canada does not have any vaccines developed by itself, and there are several vaccines in China. Do you have any brains?

 

[Indos]

You need to expand your reading list beyond 'The little red book' and 'Xi's thoughts'.

He he that little red book is not a myth, my older brother when he was assigned by Erricson to work in project in China, he get one Chinese girl friend and that girl has also come to Indonesia some years ago and I have seen that little red book........

 

[SecularNationalist]

Pakistan hasn’t developed anything. It simply manufactured the Chinese vaccine and switched the name to PakVac. After the Chinese side wasn’t impressed, they switched back to the original Chinese name for the vaccine.

If Pakistan was a student in school, it will get F for plagiarism.

Pakistan to change name of locally-developed Covid-19 vaccine to CanSino Bio

The National Institute of Health (NIH) is considering reverting to using the name CanSino Bio for the Chinese single-dose coronavirus vaccine being produced at the institute.

120,000 doses of the Covid-19 vaccine have been packed at the NIH, while a launching ceremony is expected to be held by the end of May. For the first batch of 500 doses, the NIH used PakVac, but now it is considering using the name CanSino Bio on the remaining vaccine batches.

"There has been a change of mind and the vaccine would be called CanSino Bio as the Chinese are sensitive about the names of their products," an official of the NIH

Pakistan to change name of locally-developed Covid-19 vaccine to CanSino Bio

* NIH cites name sensitivity as reason for reverting * 'PakVac' was published on the first batch of the vaccine

www.brecorder.com

Quite true.
Wrong title. It's simply a licensed version of Sinovac. Just like we produce german G3 rifle at POF.
People gave wrong titles , officially GOP never claimed it as a indigenous Pakistani production.

 

[dbc]

Canada does not have any vaccines developed by itself, and there are several vaccines in China. Do you have any brains?

is your Chinese to English translator broken?
I just posted a link clearly stating the CanSino vaccine is developed using Canadian HEK293 cell lines technology from NRC Canada.

 

[OIO]

is your Chinese to English translator broken?
I just posted a link clearly stating the CanSino vaccine is developed using Canadian HEK293 cell lines technology from NRC Canada.

Does Canada have its own vaccine? If not, what can your link show?

 

[OIO]

He he that little red book is not a myth, my older brother when he was assigned by Erricson to work in project in China, he get one Chinese girl friend and that girl has also come to Indonesia some years ago and I have seen that little red book........

If you can really understand the little red book, there will be no shit in your mind.

 

[dbc]

Does Canada have its own vaccine? If not, what can your link show?

Does the university of Pennsylvania make vaccines? No, but Pfizer BioNTech and Moderna are paying the University millions of dollars. Why? because the intellectual property for mRNA belongs to the American University.

Similarly, the intellectual property for the CanSino vaccine belongs to ...drum rolls please...NRC Canada.

The HEK 293EBNA1-6E cell line production technique belongs to NRC Canada. The Chinese are merely commercializing the vaccines by pushing the vaccine through trails, license producing and distributing for a profit.

 

[OIO]

Does the university of Pennsylvania make vaccines? No, but Pfizer BioNTech and Moderna are paying the University millions of dollars. Why? because the intellectual property for mRNA belongs to the American University.

Similarly, the intellectual property for the CanSino vaccine belongs to ...drum rolls please...NRC Canada.

The HEK 293EBNA1-6E cell line production technique belongs to NRC Canada. The Chinese are merely commercializing the vaccines by pushing the vaccine through trails, license producing and distributing for a profit.

Canada is not the United States. In fact, Pfizer’s vaccine was developed in Germany. I don’t think Canada has the core technology of vaccines. It may be a bit of technology, but it is not the core technology for China to rely on.